» Articles » PMID: 22236508

Invasive Findings in Patients with Angina Equivalent Symptoms but No Coronary Artery Disease; Results from the Heart Quest Cohort Study

Overview
Journal Int J Cardiol
Publisher Elsevier
Date 2012 Jan 13
PMID 22236508
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The cause of angina in patients presenting at coronary angiography without significant coronary artery disease (CAD) has not been systematically assessed in a large prospective cohort. This study is aimed to identify the cause of angina in these patients.

Methods: This prospective cohort comprised 718 consecutive patients with angina equivalent symptoms and no CAD (defined as no coronary stenosis ≥ 50%) between January 1st 1997 and July 31st 2008. All patients underwent additional invasive testing (intracoronary acetylcholine administration, fast atrial pacing). Small vessel and vasospastic diseases were diagnosed according to symptoms and vessel reaction during testing.

Results: Mean age was 56.3 ± 11.0 years (range 15 to 81 years). A majority of 431 patients (60.0%) had small vessel and/or vasospastic disease (233 patients had small vessel disease, 145 vasospastic disease and 53 a combination of both). Additional 87 patients (12.1%) had another cardiac disease. Only in a minority of 200 study participants (27.9%) that the symptoms were attributed to an extracardiac problem. Patients with small vessel disease were more likely to be female, to have hypertension, to have a family history of CAD and to have effort-related symptoms. Patients with vasospastic disease were more likely to be current smokers, to have angina at rest or to present as myocardial infarction, and to have coronary sclerosis and/or endothelial dysfunction.

Conclusions: In a majority of patients with angina but no significant CAD, a cardiac cause of their symptoms can be found. Systematical invasive testing may help optimizing the medical management of these patients.

Citing Articles

Should the Right Coronary Artery Be Routinely Assessed During Provocative Spasm Testing?.

Girolamo O, Tavella R, Di Fiore D, Sheikh A, Pasupathy S, Ooi E J Clin Med. 2025; 14(4).

PMID: 40004885 PMC: 11856602. DOI: 10.3390/jcm14041355.


The Need for Separate Testing with Acetylcholine for the Assessment of Endothelial Dysfunction and Coronary Artery Spasm.

Sueda S, Sakaue T Eur Cardiol. 2024; 19:e17.

PMID: 39449721 PMC: 11499973. DOI: 10.15420/ecr.2022.16.


A Review of the Role of Tests of Coronary Reactivity in Clinical Practice.

Sueda S, Sakaue T Eur Cardiol. 2024; 19:e16.

PMID: 39220616 PMC: 11363052. DOI: 10.15420/ecr.2022.12.


Intracoronary acetylcholine testing among 746 consecutive Japanese patients with angina-like chest pain and unobstructed coronary artery disease.

Sueda S, Sakaue T Eur Heart J Open. 2022; 2(1):oeab012.

PMID: 35919663 PMC: 9242056. DOI: 10.1093/ehjopen/oeab012.


Effects of geriatric clinical skills training on the attitudes of medical students.

Goeldlin A, Siegenthaler A, Moser A, Stoeckli Y, Stuck A, Schoenenberger A BMC Med Educ. 2014; 14:233.

PMID: 25342579 PMC: 4287533. DOI: 10.1186/1472-6920-14-233.